PHARMENA (PHR.WA) Financials

PHR.WA Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 24.1 million 1.9 million
2023-09-30 26.2 million 3.6 million
2023-06-30 52.1 million 59.5 million
2023-03-31 12.9 million 19.8 million

PHR.WA Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -348000 ?
2023-09-30 -12.3 million ?
2023-06-30 44.7 million ?
2023-03-31 701000 ?

PHR.WA Net Income

No data available :(

PHR.WA Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 - - 181000
2023-09-30 - - 331000
2023-06-30 - - 327000
2023-03-31 - - 441000

PHR.WA Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 11.1 million
2023-09-30 11.1 million
2023-06-30 11.1 million
2023-03-31 11.1 million

PHR.WA Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 95000 - 4.6 million -
2023-09-30 - - 1.1 million -
2023-06-30 131000 - 731000 -
2023-03-31 102000 - 2.9 million -

PHR.WA Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 9.7 million 3.8 million
2023-09-30 5000 24000
2023-06-30 -4.6 million -1.5 million
2023-03-31 4.7 million 1.7 million

PHR.WA

Price: PLN6.32

52 week price:
5.30
9.18

Earnings Per Share: 2.60 PLN

P/E Ratio: 2.41

Exchange: WSE

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 69.7 million

Average Dividend Frequency: 1

Links: